Cyclerion Therapeutics, Inc.·4

Jun 4, 4:56 PM ET

Isacson Ole 4

4 · Cyclerion Therapeutics, Inc. · Filed Jun 4, 2019

Insider Transaction Report

Form 4
Period: 2019-06-01
Isacson Ole
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-06-01+10,00010,000 total
    Exercise: $13.95Exp: 2029-06-01Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION